UBE2T and Ewing sarcoma: Furthermore, validation set and IHC findings displayed that the expression level of UBE2T was significantly higher in the sick tissues of Ewing’s sarcoma patients than the control group, and IHC analysis revealed that UBE2T was mostly expressed in the cytoplasm of Ewing’s sarcoma cells (Figures 4E, F).